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Abstract
Quantification of oversulfated chondroitin sulfate (OSCS) in biomedical heparin preparations is achieved using a
recently described potentiometric polyanion sensor-based approach operated in a kinetic mode of analysis. This is
accomplished by adjusting the concentration of the test sample to a range where the OSCS level is low enough for the
sensor not to achieve a full and rapid equilibrium phase boundary potential change at the membrane/sample interface
upon exposure to the heparin sample. Using this method, the OSCS wt% determined within heparin samples
containing OSCS are shown to be in good agreement with those determined by an accepted NMR method.
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Heparin, a highly-sulfated glycosaminoglycan, is widely
used as an anticoagulant both intravenously and subcuta-
neously [1 – 3]. A variety of medical devices and diagnostic
products may also contain or be coated with heparin.
Recently, hundreds of cases of an acute, rapid onset allergic
type reaction (resulting in a large number of patient deaths)
have been reported to the US Food and Drug Adminis-
tration (FDA) for certain lots of heparin manufactured in
China. A specific contaminant, oversulfated chondroitin
sulfate (OSCS), has been identified in given lots of heparin
preparations that may have caused these adverse events [4,
5]. OSCS possesses a very similar polysaccharide chemical
structure and anticoagulant activity as heparin; therefore,
typical bioactivity assays [6 – 8] cannot detect the presence
of the OSCS species. To date, only complex and costly
nuclear magnetic resonance (NMR) [5, 9] and capillary
electrophoresis (CE) [10] techniques have been suggested
by FDA for the detection and quantification of the OSCS
contaminant.
It has been demonstrated previously in this laboratory
that large and reproducible EMF responses toward polyan-
ionic species can be achieved if polymeric ion-selective
electrodes (ISEs) are formulated with lipophilic anion-
exchangers, such as a tridodecylmethylammonium
(TDMA) salt, in plasticized poly(vinyl chloride) (PVC)
membranes [11 – 13]. Further, we have recently shown that
by using such simple and inexpensive potentiometric
polyanion sensors, it is possible to rapidly detect the
presence of OSCS or other high charge density polyanionic
structures as contaminants in heparin, since these species,
even when present at low levels, cause a greater negative
change in the phase boundary equilibrium potential for the
contaminated heparin than for the untainted heparin. This is
due to the higher charge density of OSCS (or other potential
polyanion impurities that might exhibit heparin-like bioac-
tivity) compared to that of porcine heparin, and thus there is
a greater equilibrium constant for extraction of the OSCS
into the membrane phase to form an ion pair with the
TDMA species [14]. Indeed, earlier work has shown that the
magnitude of the equilibrium potential change for polyan-
ion sensors is directly related to polyanion charge density
[15].
The fundamental response principles of potentiometric
polyanion sensors have be described in previous studies [13,
15]. As reported in our most recent work [14], detection of
0.5 wt% OSCS impurity is readily achieved using only 1 mg/
mL of final polyion concentration, and if a more concen-
trated contaminated heparin sample is used, a lower weight
percentage of the contaminant polyanion may be detected
(i.e., an improved detection limit for contaminant wt% in
the heparin sample). Moreover, the overall potentiometric
response profile of TDMA-based membrane electrodes
toward a heparin preparation containing less than 1 wt%
OSCS shows that the measured potential first drops quickly
to the EMF change typically observed for pure heparin (ca.
50 mV in background of phosphate buffered saline with
0.141 M chloride), and then drifts down slowly toward the
value observed for the pure OSCS or the highly contami-
nated samples (see Fig. 1). We can take advantage of this
kinetic response property to quantitatively determine the
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content of the contaminant if the OSCS weight percentage
in the total polyanion preparation is adjusted to be in a range
(by dilution of the original heparin sample with pure heparin
solution) which is low enough for the electrode not to
achieve a rapid equilibrium phase boundary potential
change at the membrane/sample interface. Under such
conditions, the rate of EMF change of the membrane toward
the equilibrium EMF response for the higher charge density
OSCS species is proportional to the OSCS concentration.
The critical concentration of OSCS for the potential not
to reach equilibrium rapidly has been found to be1 wt%
when operating the electrodes at room temperature (ca.
22 8C). This operational non-equilibrium range can be
raised to higher levels of OSCS if the temperature is
increased (see Experimental Section, below). As shown in
Figure 1, when a series of standards containing synthesized
OSCS mixed in different wt% with pure porcine heparin
(with total polyanion concentration of 10 mg/mL) are
injected (diluting the sample 1: 10 in the process) into a
PBS electrolyte in which the polyanion sensor (and
reference electrode) are placed at room temperature, the
EMF changes quickly to ca. 50 mV (for pure heparin)
and then drifts down slowly toward the 75 to 78 mV
change observed for pure OSCS. If the values of DEMFare
integrated for 5 min after the injection of the polyanion
sample preparation, the integrated signal, which is propor-
tional to the rate of change over the 5 min interval, is
Fig. 1. Response time trace of PVC membranes doped with TDMAC after injection of heparin/polyion preparations (at 1 mg/mL)
possessing different degrees of OSCS contamination equal to or less than 1 wt%. For comparison, the response to pure porcine heparin
at a final polyanion concentration of 1 mg/mL is also shown.
Fig. 2. Calibration curve of the relative integrated area from OSCS for polyanion preparations with different OSCS wt%. The standard
deviations were calculated using data collected from 6 electrodes for each concentration. DEMF was integrated for 5 min after the
injection of polyanion preparation, and the relative integrated area from OSCS was calculated by subtracting the integrated area for the
pure heparin response from the polyanion mixture response.
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linearly correlated with the weight percentage of OSCS in
the polyanion standards (see Fig. 2).
Table 1 summarizes the calculated values of OSCS wt%
in several different OSCS test sample solutions prepared
with the synthesized OSCS and porcine heparin, after
diluting these samples appropriately with pure porcine
heparin solutions to fall into the standard calibration range
(See Fig. 2). In addition, data is presented in this table for a
commercial USP heparin preparation known to be con-
taminated with OSCS at a value greater than 10 wt%. As
shown in Table 1, the calculated OSCS wt% values found
by the electrode method are in close agreement to the
OSCS wt% known for the three different OSCS synthetic
sample solutions containing OSCS. The OSCS wt% in the
USP contaminated heparin was found to be 21.3 wt% and
17.7 wt%, respectively, using different dilutions of the
original sample, with the more diluted sample showing a
much larger standard deviation than the less diluted
sample.
Previous studies have shown that NMR spectroscopy
can be used to assess and quantify the OSCS impurities in
heparin by means of the intensity of the N-acetyl proton
resonance signal [16, 17]. Here, using the ratio of acetyl
proton signal of OSCS at d¼ 2.12 ppm to that of heparin
N-acetyl proton at d¼ 2.02 ppm (see Fig. 3) enables the
preparation of a calibration curve which can be used to
determine the wt% OSCS in the given polyanion prepa-
ration. As shown in Table 1, the results of OSCS wt%
values determined by potentiometric polyanion sensors
are in good agreement with the results obtained by the
NMR method for the same test samples. Moreover, the
potentiometric method to determine the OSCS wt% is
reproducible, although the slope and intersect values of
the OSCS wt% calibration curves may vary somewhat for
experiments conducted on different days owing to varia-
tions in temperature and difficulties in obtaining precisely
controlled mass transport of polyions to the surface of
the sensing membrane. Polyion mass transport and hence
reproducibility can be controlled more effectively by using
thermostatted water jacket measurement cells, and also by
using a rotating electrode version of the polyion sensor
[18]. Nonetheless, the results presented clearly indicate
that the simple potentiometric polyanion sensor-based
method described here, even when operated at
room temperature, can be applied to quantify OSCS or
other high charge density polyanion contaminants in
biomedical heparin preparations with reasonably good
accuracy.
It should be noted that although the potentiometric
response to OSCS is irreversible using the reported sensor
configuration (unless the electrodes are soaked in high
concentration sodium chloride solution in order to reverse
the ion-exchange process and allow chloride to ion-ex-
change with the extracted polyanion species), due to their
simplicity and the low cost in construction of the electrodes,
it is possible to use these sensors as single-use disposable
devices.
Experimental
OSCS was synthesized according to a previously reported
procedure starting from the sodium salt of chondroitin
sulfate (Aldrich, St. Louis, MO) and sulfur trioxide (Al-
drich) [5, 9]. A contaminated heparin known to have
>10 wt% OSCS (U.S. Pharmacopeia (USP), Rockville,
MD) was used as a reference sample. The polyanion
sensitive membranes were formulated with 1.5 wt% trido-
dedylmethylammonium chloride (TDMAC) (Aldrich),
66 wt% poly(vinyl chloride) (PVC) (Fluka, St. Louis, MO)
and 32.5 wt% dioctylsebacate (DOS) (Fluka), as reported
previously [12]. Membrane components were dissolved in
distilled tetrahydrofuran (THF) at 100 mg/mL. Fabrication
of the single-use disposable electrochemical sensors was as
described previously, using narrow bore Tygon tubing [14].
The sensors were soaked in 0.01 M PBS, pH 7.4, for
approximately 1 h before the glass capillaries were carefully
Fig. 3. 1H NMR spectra (400 MHz) of the acetyl region of the
OCSC, heparin and the USP contaminated heparin sample.
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removed. The small Tygon tubing with the sensing mem-
brane at the tip was then filled with the same PBS buffer, and
a Ag/AgCl wire covered with heat shrink tubing on the top
was inserted. To determine the OSCS wt% in polyanion
preparations by the potentiometric method, a 10 mg/mL
polyanion solution (in PBS) with OSCS wt% smaller than
1% was tested with the polyanion sensors as described
above. The values of EMF change were integrated for 5 min
after the injection of polyanion preparations. Other lengths
of integration period (e.g., 250 s and 500 s) were also
performed, which gives similar results in the calculated
value of OSCS wt%. However, longer integration time
period should be avoided in order to ensure the potentials
do not reach full equilibrium values during the integration
period. If this occurred, non-linear calibration curves would
likely result. Integrations were performed by Origin Lab 7.5
(Northampton, MA). The maximum EMF change of pure
porcine heparin is determined to be 51.2 mV with a
standard deviation of 1.6 mV (n¼ 6). The relative signal
change from OSCS response was obtained by subtracting
the area of heparin response (51.2 300¼ 15360 mV s)
from the area of the polyanion mixture response. All the
potentiometric measurements were conducted at room
temperature and the data for one calibration curve was
collected in one day. Measurements at higher temperature
(i.e., 37 8C) were also conducted and showed a similar
change in the EMF profile after the injection of the
polyanion, but the detectable OSCS concentration range
was shifted to a higher concentration range. This can be








where z is charge on polyion; Da and Dm are the diffusion
coefficients of the polyion in the aqueous sample and
membrane phases, respectively; da and dm are the diffusion
layer thicknesses in the aqueous sample and membrane
phases, respectively, RþT is the concentration of TOMA in the
membran and Cpoly is the concentration of polyanion in the
sample solution. Elevated temperature increases the diffu-
sion coefficient of the ion-pair of the extracted polyion/ion-
exchanger in the membrane phase to a greater degree than Da
and thereby shifts the range where initial non-equilibrium
EMF response occurs to higher concentrations of OSCS.
Therefore, the critical value for the potential not to reach
full equilibrium is larger than 1 wt% when operating at 378C,
which means that less dilution of the contaminated sample is
required at a higher temperature. To emphasize the lower
limits of detection of the proposed method, all electro-
chemical experiments reported in this manuscript were
carried out at room temperature.
For quantification of OSCS by the NMR method, 30 mg/
mL OSCS and heparin solutions in D2O (Cambridge
Isotope Laboratories, Inc., Andover, MA) were constantly
shaken for 1 h prior to the NMR measurements. Then, the
two solutions were mixed to give different wt% of OSCS. 1H
NMR spectra were recorded on a Varian 400 MHz spec-
trometer. For all the polyanion samples, 32 scans were
collected over a spectral width of 6400 Hz. The acquisition
time was 2.56 s, followed by a relaxation delay of 1 s. All the
spectra were recorded at 315 K using a flip angle of 308 and
the chemical shifts were reported to the solvent peak at
4.58 ppm (calculate by the equation d¼ 7.83T/96.9,
where T is the absolute temperature in Kelvin [19]) . The
data were processed by MestReNova 5.3.2 (Mestrelab
Research, Spain). Baseline corrections were mostly done
automatically, and phasing was always performed manually.
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